Milestone Pharmaceuticals Inc.
For the period ended Jun 16, 2025. Filed Jun 16, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jun 16, 2025 · Filed Jun 16, 2025
Use the contents to explore the available documents and sections.
MIST$0.76+10.2%Stored close · as of Nov 6, 2026
Contents
MILESTONE PHARMACEUTICALS INC
(Exact name of registrant as specified in its charter)
| Québec | 001-38899 | Not applicable |
|---|---|---|
| (state or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| 1111 Dr. Frederik-Philips Boulevard, | |
|---|---|
| Montréal, Québec CA | H4M 2X6 |
| (Address of principal executive offices) | (Zip Code) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.